Gine E, de la Cruz F, Jimenez Ubieto A, Lopez Jimenez J, et al. Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial. J Clin Oncol 2022 Jan 14:JCO2102321. doi: 10.1200/JCO.21.02321.
PMID: 35030036